377 related articles for article (PubMed ID: 20809665)
1. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.
Secoli SR; Figueras A; Lebrão ML; de Lima FD; Santos JL
Drugs Aging; 2010 Sep; 27(9):759-70. PubMed ID: 20809665
[TBL] [Abstract][Full Text] [Related]
2. Age-related differences in the prevalence of potential drug-drug interactions in ambulatory dyslipidaemic patients treated with statins.
Egger SS; Rätz Bravo AE; Hess L; Schlienger RG; Krähenbühl S
Drugs Aging; 2007; 24(5):429-40. PubMed ID: 17503898
[TBL] [Abstract][Full Text] [Related]
3. Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.
Ismail M; Iqbal Z; Khattak MB; Khan MI; Arsalan H; Javaid A; Gul Q; Khan F
Int J Clin Pharm; 2013 Jun; 35(3):455-62. PubMed ID: 23483444
[TBL] [Abstract][Full Text] [Related]
4. Are patients with a nasally placed feeding tube at risk of potential drug-drug interactions? A multicentre cross-sectional study.
Gimenes FRE; Baysari M; Walter S; Moreira LA; Carvalho REFL; Miasso AI; Faleiros F; Westbrook J
PLoS One; 2019; 14(7):e0220248. PubMed ID: 31365563
[TBL] [Abstract][Full Text] [Related]
5. Potential drug-drug interactions associated with adverse clinical outcomes and abnormal laboratory findings in patients with malaria.
Noor S; Ismail M; Khadim F
Malar J; 2020 Aug; 19(1):316. PubMed ID: 32867788
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Drug-Related Problems in Chronic Kidney Disease Patients.
Shouqair TM; Rabbani SA; Sridhar SB; Kurian MT
Cureus; 2022 Apr; 14(4):e24019. PubMed ID: 35573572
[TBL] [Abstract][Full Text] [Related]
7. Review of prescription medications in home-based older adults with stroke: a pilot study.
Classen S; Meuleman J; Garvan C; Ried LD; Mann W; Asal N
Res Social Adm Pharm; 2007 Mar; 3(1):104-22. PubMed ID: 17350560
[TBL] [Abstract][Full Text] [Related]
8. Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.
Ranzani A; Oreni L; Agrò M; van den Bogaart L; Milazzo L; Giacomelli A; Cattaneo D; Gervasoni C; Ridolfo AL
J Acquir Immune Defic Syndr; 2018 Jun; 78(2):193-201. PubMed ID: 29767640
[TBL] [Abstract][Full Text] [Related]
9. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
[TBL] [Abstract][Full Text] [Related]
10. Potential drug-drug interactions among pneumonia patients: do these matter in clinical perspectives?
Noor S; Ismail M; Ali Z
BMC Pharmacol Toxicol; 2019 Jul; 20(1):45. PubMed ID: 31349877
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Polypharmacy and Potential Drug-Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study.
Altunal LN; Yagcı Caglayık D; Ozel AS; Tukenmez Tigen E; Sili U; Erturk Sengel B; Aydın M; Korten V
AIDS Patient Care STDS; 2023 Mar; 37(3):138-145. PubMed ID: 36812461
[TBL] [Abstract][Full Text] [Related]
12. Drug-Drug Interactions in Hepatitis Patients: Do these Interactions Matter in Clinical Perspectives?
Noor S; Ismail M; Haider I; Khadim F
Ann Hepatol; 2018 Oct; 17(6):1001-1011. PubMed ID: 30600298
[TBL] [Abstract][Full Text] [Related]
13. Potential Drug-Drug Interactions in Patients With Urinary Tract Infections: A Contributing Factor in Patient and Medication Safety.
Noor S; Ismail M; Khan F
Front Pharmacol; 2019; 10():1032. PubMed ID: 31607905
[No Abstract] [Full Text] [Related]
14. Potentially inappropriate prescribing and drug-drug interactions among elderly Chinese nursing home residents in Macao.
Lao CK; Ho SC; Chan KK; Tou CF; Tong HH; Chan A
Int J Clin Pharm; 2013 Oct; 35(5):805-12. PubMed ID: 23812679
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of potential drug-drug interactions in older adults with psychiatric disorders: a retrospective study.
Liu Y; Yang M; Ding Y; Wang H; Zhang H; Wang D; Zhuang T; Ji M; Cui Y; Wang H
BMC Psychiatry; 2022 Aug; 22(1):563. PubMed ID: 35996119
[TBL] [Abstract][Full Text] [Related]
16. Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments.
Fokter N; Mozina M; Brvar M
Wien Klin Wochenschr; 2010 Feb; 122(3-4):81-8. PubMed ID: 20213374
[TBL] [Abstract][Full Text] [Related]
17. Potential Drug-Drug Interactions Among Hospitalised Elderly Patients in Northern Sri Lanka, A Lower Middle-Income Country: A Retrospective Analysis.
Navaratinaraja TS; Kumanan T; Siraj S; Sreeharan N
Drugs Real World Outcomes; 2023 Mar; 10(1):83-95. PubMed ID: 36380216
[TBL] [Abstract][Full Text] [Related]
18. The impact of treatment choices on potential drug-drug interactions in hypertensive patients.
Perić A; Udilović A; Dobrić S; Vezmar Kovačević S
Br J Clin Pharmacol; 2022 May; 88(5):2340-2348. PubMed ID: 34862631
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Potential Drug-drug Interactions With Ritonavir-containing COVID-19 Therapy in the United States: An Analysis of the National Health and Nutrition Examination Survey.
Igho-Osagie E; Brzozowski K; Jin H; Brown J; Williams MG; Puenpatom A
Clin Ther; 2023 May; 45(5):390-399.e4. PubMed ID: 37032225
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of potential drug-drug interactions in elderly population admitted to critical care units of Peshawar, Pakistan.
Shakeel F; Aamir M; Khan AF; Khan TN; Khan S
BMC Pharmacol Toxicol; 2018 Dec; 19(1):85. PubMed ID: 30526670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]